Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW 9,730.00
-220.00 (-2.21%)
At close: Jul 14, 2026
Whan In Pharm Market Cap
Whan In Pharm has a market cap or net worth of 179.85 billion as of July 14, 2026. Its market cap has decreased by -1.34% in one year.
Market Cap
179.85B
Enterprise Value
116.81B
Revenue
266.19B
Ranking
n/a
PE Ratio
10.17
Stock Price
9,730.00
Market Cap Chart
Since June 24, 1997, Whan In Pharm's market cap has increased from 51.22B to 179.85B, an increase of 251.13%. That is a compound annual growth rate of 4.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 179.85B | 4.07% |
| Dec 30, 2025 | 172.82B | -4.15% |
| Dec 30, 2024 | 180.30B | -21.48% |
| Dec 28, 2023 | 229.62B | -14.55% |
| Dec 29, 2022 | 268.70B | -1.12% |
| Dec 30, 2021 | 271.75B | 6.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suheung | 220.50B |
| Yungjin Pharm. | 216.36B |
| FutureChem Co.,Ltd | 205.16B |
| Chong Kun Dang Holdings | 187.57B |
| REYON Pharmaceutical | 184.69B |
| JW Lifescience | 176.37B |
| Daewon Pharmaceutical | 171.47B |
| BNC KOREA | 171.33B |